Skip to content

CRIS

Curis, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.35
−1.46%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue4.3M9.4M10.9M10.0M10.2M
Cost of Revenue31.0K45.0K98.0K212.0K257.0K
Gross Profit4.3M9.4M10.8M9.8M9.9M
Operating Expenses
R&D Expense25.4M28.3M38.6M39.5M43.3M
SG&A Expense14.8M14.0M16.8M18.6M19.6M
General & Admin Expense14.8M14.0M16.8M18.6M19.6M
Selling & Marketing Expense
Other Expenses45.0K
Total Operating Expenses40.2M42.3M55.4M58.1M62.9M
Cost and Expenses40.3M42.3M55.5M58.4M63.2M
Operating Income (EBIT)(36.0M)(32.9M)(44.5M)(48.3M)(53.0M)
Non-Operating
Interest Income270.0K316.0K1.8M2.9M1.1M
Interest Expense2.2M615.0K2.0M4.8M
Net Interest Income270.0K(1.9M)1.2M919.0K(3.7M)
Other Non-Op Income/Expense14.8M25.3M1.2M919.0K(3.7M)
Non-Operating Income (excl Interest)(14.0M)(27.5M)(1.8M)(2.9M)(1.1M)
EBT (Pre-Tax Income)(21.2M)(7.6M)(43.4M)(47.4M)(56.7M)
Income Tax Expense
Bottom Line
Net Income(21.2M)(7.6M)(43.4M)(47.4M)(56.7M)
Earnings from Cont. Ops(21.2M)(7.6M)(43.4M)(47.4M)(56.7M)
Earnings from Discont. Ops
Bottom Line Net Income(21.2M)(7.6M)(43.4M)(47.4M)(56.7M)
Per Share
Basic EPS($14.22)($11.60)($137.60)($179.20)($242.80)
Diluted EPS($14.22)($11.60)($137.60)($179.20)($242.80)
Revenue Per Share$2.02$14.35$34.59$37.87$43.52
Shares
Basic Shares Outstanding2.1M658201315314264664233481
Diluted Shares Outstanding2.1M658201315314264664233481
Profitability Metrics
EBITDA(21.8M)(5.2M)(42.6M)(45.1M)(51.7M)
D&A94.0K169.0K203.0K255.0K233.0K
EBIT(21.9M)(5.4M)(42.8M)(45.4M)(51.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026